Drug profile

The FDA adverse-event record for Unspecified Pain Medication

46 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Unspecified Pain Medication. See the species affected, top reactions, and outcomes below.

46
adverse-event reports
17.4%
death-coded share
Dog
most-reported species
12
Vomiting - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
46
Total Reports
8
Deaths Reported
17.4%
Death Rate

Active Ingredients

Unspecified Pain Medication

Administration Routes

UnknownOral

Species Affected

Dog 35
Cat 10
Human 1

Most Affected Breeds

Domestic Shorthair 6
Retriever - Labrador 6
Retriever - Golden 3
Terrier - Bull 2
Rottweiler 2
Dog (unknown) 2
Domestic Longhair 1
Crossbred Canine/dog 1
Terrier - Jack Russell 1
Bichon Frise 1

Most Reported Reactions

Vomiting 12
Weight loss 5
Diarrhoea 5
Not eating 5
Lethargy (see also Central nervous system depression in 'Neurological') 4
Death 4
Behavioural disorder NOS 4
Death by euthanasia 4
Lack of efficacy - NOS 4
Panting 4
Pain NOS 4
Anorexia 3

Outcome Breakdown

Ongoing
14 (30.4%)
Recovered/Normal
13 (28.3%)
Outcome Unknown
11 (23.9%)
Died
4 (8.7%)
Euthanized
4 (8.7%)

Unspecified Pain Medication Adverse Event Insights

46 reports name Unspecified Pain Medication; 8 recorded a death outcome (17.4% of reported events, not a population-level mortality rate). Active ingredient: Unspecified Pain Medication. Administration routes: Unknown, Oral.

By species: Dog (35 reports), Cat (10 reports), Human (1 reports). By breed: Domestic Shorthair (6), Retriever - Labrador (6), Retriever - Golden (3).

Leading clinical signs: Vomiting (12), Weight loss (5), Diarrhoea (5), Not eating (5). Outcome, 46 coded reports: Ongoing leads at 30.4%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.